Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, la Cour CM, Martin WF, Mithieux G, Moreira PI, Murphy MP, Nave KA, Nuriel T, Oliet SHR, Saudou F, Mattson MP, Swerdlow RH, Millan MJ
Vitamin C protects the skin from the environment while Kojic Acid treats existing discoloration
Lifestyle factors: adequate protein, vitamin C, copper-zinc balance, and sleep Low-potency vial: KLOW purity and mass
most comparators (treatment differences: 0.42 to 1.32%)
CiscarMTrinidadEPerez-ChaconGAlsaleemMJimenezMJimenez-SantosMet alRANK is a poor prognosis marker and a therapeutic target in ER-negative postmenopausal breast cancer
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023